A biochemical study on combined treatment of experimental silicosis with tetradrine-PVNO and tetradrine-QOHP in rats

Biomed Environ Sci. 1995 Sep;8(3):265-8.

Abstract

A better understanding is needed to explain the mechanism of therapeutic effect of combined use of tetradrine-PVNO and tetradrine-QOHP which play very important roles in treatment of silicosis. Blood prolidase (PLD), monamine oxidase (MAO) and plasminogen (PLG) in silicotic rats after treatment with tetradrine-PVNO or tetradrine-QOHP were measured. The values obtained were compared with the untreated silicotic rats. It was found that the silicotic rats that received tetradrine-PVNO showed significant increase in PLD and decrease in PLG, but no significant change in MAO. The PLD in plasma of silicotic rats that received tetradrine-QOHP were elevated significantly, but PLG and MAO did not change appreciably. These findings suggest that the combined use of tetradrine-PVNO and tetradrine-QOHP can accelerate the degradation of collagen in silicotic rats.

MeSH terms

  • Alkaloids / administration & dosage
  • Alkaloids / therapeutic use*
  • Animals
  • Benzylisoquinolines*
  • Dipeptidases / blood
  • Male
  • Monoamine Oxidase / blood
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use*
  • Plasminogen / metabolism
  • Polyvinylpyridine N-Oxide / administration & dosage
  • Polyvinylpyridine N-Oxide / therapeutic use*
  • Rats
  • Rats, Wistar
  • Silicosis / blood
  • Silicosis / drug therapy*
  • Silicosis / enzymology
  • Silicosis / metabolism

Substances

  • Alkaloids
  • Benzylisoquinolines
  • Piperazines
  • tetrandrine
  • Plasminogen
  • Polyvinylpyridine N-Oxide
  • Monoamine Oxidase
  • Dipeptidases
  • proline dipeptidase